1.Research progress of statins in the prevention and treatment of colorectal cancer
Mingxin TANG ; Xiaolin WANG ; Xuanfei LI
The Journal of Practical Medicine 2024;40(14):2041-2046
Statins,known as hydroxymethylglutaryl coenzyme A reductase(HMG-CoA)inhibitors,are primarily used to lower blood lipids,preventing and treating cardiovascular diseases.Research indicates that statins exhibit multiple effects in the prevention and treatment of colorectal cancer.They function by inhibiting the MVA pathway,suppressing inflammation,enhancing cellular immunity,and influencing the gut microbiota,positively impacting the onset and progression of colorectal cancer.Clinical studies have additionally uncovered that statin drugs can augment the effectiveness of chemotherapy,immunotherapy,and adjuvant therapies,acting as both pre-ventive and adjunctive measures for colorectal cancer.This article critically reviews the research progress on statins in colorectal cancer,aiming to establish a theoretical foundation for exploring innovative treatment options.
2.Preparation and application of PRRSV MS2 armored virus-like particles qualityas control products
Jiamin HE ; Xuanfei PANG ; Lyu LUO ; Jiazhen YANG ; Baozhen ZHANG ; Jianmin WU ; Wenna LIU ; Zhongsheng LI ; Yiquan BAI
Chinese Journal of Veterinary Science 2024;44(11):2316-2323
In order to develop a positive quality control products for the detection of porcine repro-ductive and respiratory syndrome virus(PRRSV)nucleic acid by real-time fluorescent quantitative PCR(RT-qPCR),the positive quality control products of PRRSV-1 and PRRSV-2 M genes were prepared using armored RNA technology of MS2 phage.PRRSV-1 and PRRSV-2 M genes were amplified,purified and recovered,and ligated into pET28b vector containing MS2 mature enzyme protein gene and capsid protein.After transformed into BL21(DE3),the gene products were in-duced by IPTG and purified by PEG6000 precipitation method to prepare the armored RNA virus-like particles(AR-PRRSV)containing PRRSV M gene.Following the performance evaluation,as the positive quality control products of PRRSV-1 and PRRSV-2 M genes,AR-PRRSV1M and AR-PRRSV2M were calculated using YY/T 1652-2019 standard.Results showed that it had a good u-niformity,stable storage for the armored virus-like particles at-20,4,25 ℃ for 60 d,and 37 ℃ for 30 d.The prepared armored virus-like particles AR-PRRSV1M and AR-PRRSV2M were deter-mined by digital quantitative PCR(ddPCR)after preliminary quantification by RT-qPCR.The 104 copies/μL of AR-PRRSV1M and AR-PRRSV2M ddPCR fixation was(1.33+0.50)× 104 cop-ies/μL.The above results indicates that the AR-PRRSVM can be used as the quality control of the whole detection process(nucleic acid extraction,reverse transcription and RT-qPCR).
3.Novel perspective in transplantation therapy of mesenchymal stem cells: targeting the ferroptosis pathway.
Yuzhu XU ; Pan FAN ; Lei LIU ; X U XUANFEI ; Lele ZHANG ; Jiadong WANG ; Yuao TAO ; Xiaolong LI ; Xi LI ; Yuntao WANG
Journal of Zhejiang University. Science. B 2023;24(2):115-129
Ex vivo culture-amplified mesenchymal stem cells (MSCs) have been studied because of their capacity for healing tissue injury. MSC transplantation is a valid approach for promoting the repair of damaged tissues and replacement of lost cells or to safeguard surviving cells, but currently the efficiency of MSC transplantation is constrained by the extensive loss of MSCs during the short post-transplantation period. Hence, strategies to increase the efficacy of MSC treatment are urgently needed. Iron overload, reactive oxygen species deposition, and decreased antioxidant capacity suppress the proliferation and regeneration of MSCs, thereby hastening cell death. Notably, oxidative stress (OS) and deficient antioxidant defense induced by iron overload can result in ferroptosis. Ferroptosis may inhibit cell survival after MSC transplantation, thereby reducing clinical efficacy. In this review, we explore the role of ferroptosis in MSC performance. Given that little research has focused on ferroptosis in transplanted MSCs, further study is urgently needed to enhance the in vivo implantation, function, and duration of MSCs.
Humans
;
Antioxidants/metabolism*
;
Ferroptosis
;
Mesenchymal Stem Cell Transplantation
;
Mesenchymal Stem Cells
;
Iron Overload/metabolism*